FINWIRES — Financial News

HC Wainwright Initiates Immuneering at Buy With $14 Price Target

Immuneering (IMRX) has an average rating of buy and mean price target of $18.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$IMRX

Research1d ago

HC Wainwright Initiates Atrium Therapeutics at Buy, With $25 Price Target

$RNA

Research1d ago

Wells Fargo Downgrades AppLovin to Equalweight From Overweight, Adjusts PT to $357 From $575

AppLovin (APP) has an average rating of buy and mean price target of $638.59, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$APP

Research1d ago

Nomura Downgrades United Tractors to Neutral From Buy, Adjusts Price Target to IDR27,000 From IDR39,200

IDX:UNTR

Research1d ago

Krungsri Securities Upgrades North East Rubber to Buy from Neutral; Price Target is THB5.30

North East Rubber (BKK:NER) has an average rating of overweight and mean price target of 4.90 baht, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

BKK:NER

Research1d ago

Bocom International Starts Shenzhen Ldrobot at Buy with HK$49.14 Price Target

HKG:1236

Research1d ago

Phillip Securities Upgrades CH Karnchang to Buy from Accumulate; Price Target is THB21.60

CH Karnchang (BKK:CK) has an average rating of buy and mean price target of 23.77 baht, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

BKK:CK

Research1d ago

Masterlink Securities Upgrades Alltop Technology to Buy from Hold; Price Target is NT$360

TWO:3526

Research1d ago

Yuanta Securities Upgrades Advantech to Buy from Hold; Price Target is NT$760

Advantech (TPE:2395) has an average rating of overweight and mean price target of NT$595.81, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

TPE:2395

Research1d ago

AmInvestment Bank Downgrades Public Bank to Hold from Buy; Price Target is MYR5.60

Public Bank (KLSE:PBBANK) has an average rating of overweight and mean price target of 5.50 ringgit, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

KLSE:PBBANK

Research1d ago

TA Securities Downgrades Heineken Malaysia to Hold from Buy; Price Target is MYR19.40

Heineken Malaysia (KLSE:HEIM) has an average rating of buy and mean price target of 26.25 ringgit, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

KLSE:HEIM

Research1d ago

Inter-Pacific Research Downgrades Frontken to Neutral from Buy; Price Target is MYR5.04

Frontken (KLSE:FRONTKN) has an average rating of buy and mean price target of 5.47 ringgit, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

KLSE:FRONTKN

Research1d ago

Truist Downgrades Insulet to Hold From Buy, Adjusts Price Target to $153 From $210

Insulet (PODD) has an average rating of overweight and mean price target of $185.43, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PODD

Research1d ago

Yuanta Securities Upgrades Synnex (Thailand) to Buy from Hold; Price Target is THB12

Synnex (Thailand) (BKK:SYNEX) has an average rating of overweight and mean price target of 11.43 baht, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

BKK:SYNEX

Research1d ago

Macquarie Downgrades Subaru to Neutral from Outperform; Price Target is 2,200 Yen

Subaru (TYO:7270) has an average rating of hold and mean price target of 2,753.12 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

TYO:7270

Research1d ago

Western Securities Starts Beijing Sun-Novo Pharmaceutical Research at Add with 69.59 Yuan Price Target

SHA:688621

Research1d ago

BTIG Downgrades Insulet to Neutral From Buy

Insulet (PODD) has an average rating of overweight and mean price target of $185.43, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PODD

Research1d ago

JPMorgan Downgrades Insulet to Neutral From Overweight, Adjusts PT to $152 From $275

Insulet (PODD) has an average rating of overweight and mean price target of $189.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PODD

Research1d ago

Wells Fargo Downgrades Insulet to Equalweight From Overweight, Adjusts PT to $144 From $255

Insulet (PODD) has an average rating of overweight and mean price target of $189.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PODD

Research1d ago

Oppenheimer Downgrades Insulet to Market Perform From Outperform

Insulet (PODD) has an average rating of overweight and mean price target of $189.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PODD

Financial News · Live Terminal

HC Wainwright Initiates Immuneering at Buy With $14 Price Target

HC Wainwright Initiates Atrium Therapeutics at Buy, With $25 Price Target

Wells Fargo Downgrades AppLovin to Equalweight From Overweight, Adjusts PT to $357 From $575

Nomura Downgrades United Tractors to Neutral From Buy, Adjusts Price Target to IDR27,000 From IDR39,200

Krungsri Securities Upgrades North East Rubber to Buy from Neutral; Price Target is THB5.30

Bocom International Starts Shenzhen Ldrobot at Buy with HK$49.14 Price Target

Phillip Securities Upgrades CH Karnchang to Buy from Accumulate; Price Target is THB21.60

Masterlink Securities Upgrades Alltop Technology to Buy from Hold; Price Target is NT$360

Yuanta Securities Upgrades Advantech to Buy from Hold; Price Target is NT$760

AmInvestment Bank Downgrades Public Bank to Hold from Buy; Price Target is MYR5.60

TA Securities Downgrades Heineken Malaysia to Hold from Buy; Price Target is MYR19.40

Inter-Pacific Research Downgrades Frontken to Neutral from Buy; Price Target is MYR5.04

Truist Downgrades Insulet to Hold From Buy, Adjusts Price Target to $153 From $210

Yuanta Securities Upgrades Synnex (Thailand) to Buy from Hold; Price Target is THB12

Macquarie Downgrades Subaru to Neutral from Outperform; Price Target is 2,200 Yen

Western Securities Starts Beijing Sun-Novo Pharmaceutical Research at Add with 69.59 Yuan Price Target

BTIG Downgrades Insulet to Neutral From Buy

JPMorgan Downgrades Insulet to Neutral From Overweight, Adjusts PT to $152 From $275

Wells Fargo Downgrades Insulet to Equalweight From Overweight, Adjusts PT to $144 From $255

Oppenheimer Downgrades Insulet to Market Perform From Outperform

HC Wainwright Initiates Immuneering at Buy With $14 Price Target

HC Wainwright Initiates Atrium Therapeutics at Buy, With $25 Price Target

Wells Fargo Downgrades AppLovin to Equalweight From Overweight, Adjusts PT to $357 From $575

Nomura Downgrades United Tractors to Neutral From Buy, Adjusts Price Target to IDR27,000 From IDR39,200

Krungsri Securities Upgrades North East Rubber to Buy from Neutral; Price Target is THB5.30

Bocom International Starts Shenzhen Ldrobot at Buy with HK$49.14 Price Target

Phillip Securities Upgrades CH Karnchang to Buy from Accumulate; Price Target is THB21.60

Masterlink Securities Upgrades Alltop Technology to Buy from Hold; Price Target is NT$360

Yuanta Securities Upgrades Advantech to Buy from Hold; Price Target is NT$760

AmInvestment Bank Downgrades Public Bank to Hold from Buy; Price Target is MYR5.60

TA Securities Downgrades Heineken Malaysia to Hold from Buy; Price Target is MYR19.40

Inter-Pacific Research Downgrades Frontken to Neutral from Buy; Price Target is MYR5.04

Truist Downgrades Insulet to Hold From Buy, Adjusts Price Target to $153 From $210

Yuanta Securities Upgrades Synnex (Thailand) to Buy from Hold; Price Target is THB12

Macquarie Downgrades Subaru to Neutral from Outperform; Price Target is 2,200 Yen

Western Securities Starts Beijing Sun-Novo Pharmaceutical Research at Add with 69.59 Yuan Price Target

BTIG Downgrades Insulet to Neutral From Buy

JPMorgan Downgrades Insulet to Neutral From Overweight, Adjusts PT to $152 From $275

Wells Fargo Downgrades Insulet to Equalweight From Overweight, Adjusts PT to $144 From $255

Oppenheimer Downgrades Insulet to Market Perform From Outperform